Cortical Microstructure in AD Patients Treated with Lecanemab – Six‐Month Update on an Ongoing Real‐World Observational Study

Abstract

Background: Measures of cortical microstructure from diffusion MRI (dMRI) have been shown to relate to amyloid pathology and to neuroinflammation, and can predict subsequent macrostructural atrophy (Torso et al., 2022, PMID:36281682). We have previously shown practicality of these methods using 1.

The paper